Rahsaan Thompson
General Counsel, Gritstone bio, Inc.
Companies
- ZEVRA THERAPEUTICS, INC.General counsel Jun 25, 2024 to now1
- Lyell Immunopharma, Inc.General counsel Oct 3, 2022 to Feb 28, 20232
- Gritstone bio, Inc.General counsel Apr 14, 2020 to Apr 20, 20223
- Gritstone bio, Inc.Officer Mar 10, 2021 to Mar 10, 20214
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ZEVRA THERAPEUTICS, INC. ZVRA37,569 shares5$382.1K at $10.17Aug 14, 2026
- Gritstone bio, Inc.58,698 shares6Jan 31, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 14, 2026Sold 42,666 shares at $11.13 of ZEVRA THERAPEUTICS, INC.5
- Jun 22, 2026Sold 34,557 shares at $12.68 of ZEVRA THERAPEUTICS, INC.7
- Jun 21, 2026Exercised options 66,667 shares of ZEVRA THERAPEUTICS, INC.7
- May 11, 2026Sold 1,794 shares at $11.30 of ZEVRA THERAPEUTICS, INC.8
- Jan 30, 2026Sold 4,080 shares at $8.83 of ZEVRA THERAPEUTICS, INC.9
- Jan 30, 2026Exercised options 11,333 shares of ZEVRA THERAPEUTICS, INC.9
- Jun 26, 2025Sold 24,000 shares at $9.21 of ZEVRA THERAPEUTICS, INC.10
- Jun 21, 2025Exercised options 66,666 shares of ZEVRA THERAPEUTICS, INC.11
- Jan 31, 2022Granted 19,240 shares of Gritstone bio, Inc.6
- Jan 7, 2021Granted 25,500 shares of Gritstone bio, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARGritstone bio, Inc., General counsel
- 4SEC EDGARGritstone bio, Inc., Officer
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 23, 2026
- 8SEC EDGARForm 4 filed May 13, 2026
- 9SEC EDGARForm 4 filed Feb 2, 2026
- 10SEC EDGARForm 4 filed Jun 30, 2025
- 11SEC EDGARForm 4 filed Jun 24, 2025
- 12SEC EDGARForm 4 filed Nov 19, 2021